Dr Annalisa Mupo
Position: Senior Research Associate
Personal home page:
PubMed journal articles - click here
Acute myeloid leukemia (AML) is a molecularly diverse malignancy representing 15-20% of all childhood and around 35% of all adult leukemias. My work aims to study commonly occurring mutations in AML-NK (normal karyotype) using sophisticated mouse models.
Symplectic Elements feed provided by Research Information, University of Cambridge
Article: A powerful molecular synergy between mutant Nucleophosmin and Flt3-ITD drives acute myeloid leukemia in mice.A Mupo · L Celani · O Dovey · J L Cooper · C Grove · R Rad · P Sportoletti · B Falini · A Bradley · G S Vassiliou Article: Mouse models of NPM1-mutated acute myeloid leukemia: Biological and clinical implications P Sportoletti · E Varasano · R Rossi · A Mupo · E Tiacci · G Vassiliou · M P Martelli · B Falini